2021

Olamkicept in IBD

Adalimumab high dose+azathioprine vs ADA alone in CD strictures

Etrolizumab vs infliximab in UC

Discontinuation of infliximab in patients with ulcerative colitis in remission (HAYABUSA): a multicentre, open-label, randomised controlled trial

IFX IV vs SC in IBD

Low-Fat, High-Fiber Diet Reduces Markers of Inflammation and Dysbiosis and Improves Quality of Life in UC

IFX induction TDM or standard of care

COVID infection in IBD

Mediterranean diet or Simple Carbohydrate Diet in CD

Exclusive enteral nutrition in ASUC